Beckman Coulter Diagnostics is embarking on an innovation collaboration with Johns Hopkins Medicine to explore co-innovation initiatives with the goal of developing and commercializing novel solutions that address challenges in healthcare. For over a century, Johns Hopkins has enhanced research outcomes and advanced scholarship through the rigorous application of innovative methodologies and research approaches. For Beckman Coulter, this is an opportunity to learn from some of the best clinical minds in real-time and in a real-world setting. Through this collaboration, Beckman Coulter will benefit from observing Johns Hopkins’ researchers and clinicians as they work to develop new technologies and concepts, which represent medical breakthroughs that can potentially help patients.
Moreover, they will be able to test solutions on-site with experts who are working toward better patient care. Eventually, these solutions may be brought to the market and could contribute to elevating healthcare. Johns Hopkins’ faculty, students, and start-up community are expected to benefit from Beckman Coulter Diagnostics’ expertise in global commercialization of diagnostic solutions. This should help accelerate the translational process from world-class research to healthcare application.